CoChat

Inhibition of hepcidin transcription by growth factors

Open access
Goodnough, Julia B., Ramos, Emilio, Nemeth, Elizabeta, Ganz, Tomas · 2012 · Hepatology
Cited by 109

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

The hepatic peptide hormone hepcidin controls the duodenal absorption of iron, its storage, and its systemic distribution. Hepcidin production is often insufficient in chronic hepatitis C and alcoholic liver disease, leading to hyperabsorption of iron and its accumulation in the liver. Hepatocyte growth factor (HGF) and epidermal growth factor (EGF) mediate hepatic regeneration after liver injury. We examined the effect of these growth factors on hepcidin synthesis by hepatocytes. HGF and EGF treatment of primary mouse hepatocytes, as well as EGF administration in mice, suppressed hepcidin messenger RNA (mRNA) synthesis. The suppression of hepcidin by these growth factors was transcriptional, and was mediated by a direct effect of HGF and EGF on the bone morphogenetic protein (BMP) pathway regulating hepcidin synthesis. We further show that growth factors interfered with nuclear localization of activated sons of mothers against decapentaplegic (Smad) and increased the nuclear pool of the BMP transcriptional corepressor TG-interacting factor (TGIF). In a kinase screen with small-molecule kinase inhibitors, inhibitors in the PI3 kinase pathway and in the mitogen-activated ERK kinase/extracellular signal-regulated kinase (MEK/ERK) pathway prevented HGF suppression of hepcidin in primary mouse hepatocytes. Conclusion: HGF and EGF suppress hepatic hepcidin synthesis, in part through PI3 kinase MEK/ERK kinase pathways which may be modulating the nuclear localization of BMP pathway transcriptional regulators including activated Smads1/5/8 and the corepressor TGIF. EGF, HGF, and possibly other growth factors that activate similar pathways may contribute to hepcidin suppression in chronic liver diseases, promote iron accumulation in the liver, and exacerbate the destructive disease processes. (HEPATOLOGY 2012;56:291–299)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.25615

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 22

  1. Ramos, 2011, Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice., HEPATOLOGY, 53, 13331341, 10.1002/hep.24178 · DOI · Paper page
  2. Babitt, 2007, Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance., J Clin Invest, 117, 19331939, 10.1172/JCI31342 · DOI · Paper page
  3. Girelli, 2009, Reduced serum hepcidin levels in patients with chronic hepatitis C., J Hepatol, 51, 845852, 10.1016/j.jhep.2009.06.027 · DOI · Paper page
  4. Lambrecht, 2011, Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C., Gastroenterology, 140, 14901500, 10.1053/j.gastro.2011.01.053 · DOI
  5. Bhave, 2011, Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo., HEPATOLOGY, 54, 13601370, 10.1002/hep.24507 · DOI · Paper page
  6. Fausto, 2000, Liver regeneration., J Hepatol, 32, 1931, 10.1016/S0168-8278(00)80412-2 · DOI · Paper page
  7. Korchynskyi, 2002, Identification and functional characterization of distinct critically important bone morphogenetic proteinspecific response elements in the Id1 promoter., J Biol Chem, 277, 48834891, 10.1074/jbc.M111023200 · DOI · Paper page
  8. Pfaffl, 2001, A new mathematical model for relative quantification in realtime RTPCR., Nucleic Acids Res, 29, e45, 10.1093/nar/29.9.e45 · DOI · Paper page
  9. Kawabata, 1999, Signal transduction of the TGFbeta superfamily by Smad proteins., J Biochem, 125, 916, 10.1093/oxfordjournals.jbchem.a022273 · DOI
  10. Knockaert, 2006, Unique players in the BMP pathway: small Cterminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling., Proc Natl Acad Sci U S A, 103, 1194011945, 10.1073/pnas.0605133103 · DOI
  11. Onichtchouk, 1999, Silencing of TGFbeta signalling by the pseudoreceptor BAMBI., Nature, 401, 480485, 10.1038/46794 · DOI · Paper page
  12. Hata, 1998, Smad6 inhibits BMPSmad1 signaling by specifically competing with the Smad4 tumor suppressor., Genes Dev, 12, 186197, 10.1101/gad.12.2.186 · DOI · Paper page
  13. Imamura, 1997, Smad6 inhibits signalling by the TGFbeta superfamily., Nature, 389, 622626, 10.1038/39355 · DOI · Paper page
  14. MleczkoSanecka, 2010, SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression., Blood, 115, 26572665
  15. Sapkota, 2007, Balancing BMP signaling through integrated inputs into the Smad1 linker., Mol Cell, 25, 441454, 10.1016/j.molcel.2007.01.006 · DOI · Paper page
  16. Chaston, 2011, Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling., Am J Physiol Cell Physiol, 300, C888C895, 10.1152/ajpcell.00121.2010 · DOI · Paper page
  17. Kretzschmar, 1997, Opposing BMP and EGF signalling pathways converge on the TGFbeta family mediator Smad1., Nature, 389, 618622, 10.1038/39348 · DOI · Paper page
  18. Wotton, 2001, Smad transcriptional corepressors in TGF beta family signaling., Curr Top Microbiol Immunol, 254, 145164
  19. Lo, 2001, Epidermal growth factor signaling via Ras controls the Smad transcriptional corepressor TGIF., EMBO J, 20, 128136, 10.1093/emboj/20.1.128 · DOI · Paper page
  20. Fargion, 2011, Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases., Dig Liver Dis, 43, 8995, 10.1016/j.dld.2010.07.006 · DOI
  21. Mueller, 2010, Increased iron in HCV infection: collateral damage or antiviral defense?, J Hepatol, 53, 990992, 10.1016/j.jhep.2010.08.003 · DOI
  22. Lonnerdal, 2007, Iron metabolism in infants and children., Food Nutr Bull, 28, S491S499, 10.1177/15648265070284S402 · DOI

Cited by

Metadata

Authors
Goodnough, J. B., Ramos, E., Nemeth, E., & Ganz, T.
Venue
Hepatology
Published
2012-07
Volume
56
Issue
1
Pages
291-299
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2083240311
Cited by
109
References
12
FWCI
8.84
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1157 d)
Funders
  • Roche Foundation for Anemia Research (RoFAR)
  • National Institutes of Health (R01 DK065029, R01 DK082717)
  • Will Rogers Fund
  • Ruth L. Kirschstein National Research Service Award (NRSA) (F30 DK082151)
  • Ruth L. Kirschstein NRSA (GM007185)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.